Vanda Pharmaceuticals
VNDA
#8452
Rank
$0.30 B
Marketcap
$4.99
Share price
-0.80%
Change (1 day)
1.63%
Change (1 year)

Operating Margin for Vanda Pharmaceuticals (VNDA)

Operating Margin as of September 2026 (TTM): -86.06%

According to Vanda Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -86.06%. At the end of 2025 the company had an Operating Margin of -64.16%.

Operating Margin history for Vanda Pharmaceuticals from 2010 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-64.16%456.37%
2024-11.53%-450.43%
20233.29%-25.92%
20224.44%-71.83%
202115.77%23.61%
202012.76%-0.17%
201912.78%-2.65%
201813.12%-240.41%
2017-9.35%-23.78%
2016-12.26%-66.19%
2015-36.27%-190.11%
201440.25%-164.76%
2013-62.15%-28.93%
2012-87.44%166.86%
2011-32.77%-224.5%
201026.32%-103.34%
2009-788.46%
2004-27,867.38%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-140.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
27.37%-131.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.01%-113.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
42.17%-149.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40%-137.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
24.21%-128.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-556,900.00% 647,006.67%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.